Rheumatology Unit, Department of Medicine-DIMED, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy.
Rheumatology Unit, Department of Medicine-DIMED, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy.
J Autoimmun. 2014 Feb-Mar;48-49:122-7. doi: 10.1016/j.jaut.2013.11.005. Epub 2014 Jan 24.
Dermatomyositis (DM) is an idiopathic inflammatory myopathy (IIM) characterized by an inflammatory infiltrate primarily affecting the skeletal muscle and skin. Most common and peculiar cutaneous lesions include Gottron's papules, Gottron's sign and heliotrope rash. Different DM subsets have been identified until now encompassing classic DM, amyopathic DM, hypomyopathic DM, post-myopathic DM, and DM sine dermatitis. Patients with DM have a higher incidence rate of malignancy than the normal population. In these patients cancer occurs in about 30% of cases with higher occurrence in men and in elderly people. Bohan and Peter's diagnostic criteria, proposed in 1975, have been widely accepted and used until now. In the last ten years muscle immunopathology, myositis specific autoantibodies testing, and the use of new techniques of muscle imaging such as contrast-enhanced ultrasound or Magnetic Resonance Imaging have been introduced in the diagnostic work-up of patients with DM leading to the development of new diagnostic criteria.
皮肌炎(DM)是一种特发性炎症性肌病(IIM),其特征为主要影响骨骼肌和皮肤的炎症浸润。最常见和特有的皮肤病变包括 Gottron 丘疹、Gottron 征和向阳疹。迄今为止,已经确定了不同的 DM 亚型,包括经典 DM、无肌病性 DM、低肌病性 DM、肌病后 DM 和无皮肌炎的 DM。DM 患者的恶性肿瘤发病率高于普通人群。在这些患者中,癌症约占 30%,男性和老年人发病率更高。1975 年提出的 Bohan 和 Peter 的诊断标准被广泛接受并沿用至今。在过去十年中,肌肉免疫病理学、肌炎特异性自身抗体检测以及肌肉成像新技术(如对比增强超声或磁共振成像)在 DM 患者的诊断中得到了应用,从而制定了新的诊断标准。